SREBF1 and metabolic dysfunction-associated steatotic liver disease: STRING analysis revealed that the altered proteins (AMPK-α, C/EBPα, SREBP-1c, and PPARγ) are mapped into a core network (Figure 3e), which was primarily associated with two pathways: nonalcoholic fatty liver disease (NAFLD) pathway (C/EBPα, SREBP-1c, AMPKα) and AMPK signaling pathway (SREBP-1c, PPARγ, AMPKα).